| Mechanisms behind the resistance to trastuzumab in HER2-amplified breast cancer and strategies to overcome it M Luque-Cabal, P García-Teijido, Y Fernández-Pérez, ... Clinical Medicine Insights: Oncology 10, CMO. S34537, 2016 | 235 | 2016 |
| Immunotherapy with checkpoint inhibitors in patients with ovarian cancer: Still promising? A González‐Martín, L Sánchez‐Lorenzo Cancer 125, 4616-4622, 2019 | 46 | 2019 |
| First-line and maintenance therapy for ovarian cancer: current status and future directions A González-Martín, L Sánchez-Lorenzo, R Bratos, R Márquez, L Chiva Drugs 74, 879-889, 2014 | 26 | 2014 |
| A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in … A Gonzalez Martin, L Sanchez Lorenzo, N Colombo, ... International Journal of Gynecological Cancer 31 (4 (1 April 2021)), 617-622, 2021 | 23 | 2021 |
| The BRCA gene in epithelial ovarian cancer L Sánchez-Lorenzo, D Salas-Benito, J Villamayor, A Patiño-García, ... Cancers 14 (5), 1235, 2022 | 20 | 2022 |
| A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in … AG Martin, LS Lorenzo, N Colombo, RP Christensen, F Heitz, M Meirovitz, ... International Journal of Gynecologic Cancer 31 (4), 2021 | 15 | 2021 |
| Reduced folate carrier (RFC) as a predictive marker for response to pemetrexed in advanced non-small cell lung cancer (NSCLC) C Alvarez-Fernandez, Q Perez-Arnillas, L Ruiz-Echeverria, ... Investigational new drugs 32, 377-381, 2014 | 9 | 2014 |
| 235 Succor cone: is it cervical conization a protective maneuver E Chacón, N Manzour, JÁ Mínguez, D Vázquez, T Castellano, LS Lorenzo, ... International Journal of Gynecologic Cancer 30 (Suppl 4), 2020 | 6 | 2020 |
| Current management and future perspectives in metastatic HER2-positive breast cancer L Sánchez-Lorenzo, A Bachiller, C Gea, J Espinós Seminars in Oncology Nursing 40 (1), 151554, 2024 | 5 | 2024 |
| Prospective real-world gynaecological cancer clinical registry with associated biospecimens: a collaborative model to promote translational research between GEICO and the … JA López-Guerrero, M Mendiola, JA Pérez-Fidalgo, I Romero, A Torres, ... Cancers 14 (8), 1965, 2022 | 5 | 2022 |
| Splanchnic vein thrombosis in ambulatory pancreatic cancer patients receiving chemotherapy. V Pachón Olmos, S Garcia Adrian, M Cavanagh Podesta, ... Journal of Clinical Oncology 33 (15_suppl), e20658-e20658, 2015 | 5 | 2015 |
| Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study J Munárriz, G Reynés, L Sánchez-Lorenzo, E Esteban, L Basterretxea, ... Cancer Chemotherapy and Pharmacology 84, 781-789, 2019 | 4 | 2019 |
| SEOM-GEICO Clinical Guidelines on cervical cancer (2023) L Manso, A Ramchandani-Vaswani, I Romero, L Sánchez-Lorenzo, ... Clinical and Translational Oncology 26 (11), 2771-2782, 2024 | 3 | 2024 |
| SENECA study: staging endometrial cancer based on molecular classification E Chacon, F Boria, RR Lyer, F Fanfani, M Malzoni, P Bretová, AL Aznar, ... International Journal of Gynecologic Cancer 34 (9), 2024 | 3 | 2024 |
| Laboratory Cross-Comparison and Ring Test Trial for Tumor BRCA Testing in a Multicenter Epithelial Ovarian Cancer Series: The BORNEO GEICO 60-0 Study Z Garcia-Casado, A Oaknin, M Mendiola, G Alkorta-Aranburu, ... Journal of personalized medicine 12 (11), 1842, 2022 | 2 | 2022 |
| Incidence of incidental and symptomatic venous thromboembolism (VTE) and Khorana’s score in ambulatory pancreatic cancer patients receiving chemotherapy. AJ Muñoz Martin, S Garcia Adrian, L Sánchez Lorenzo, EM De Castro, ... Journal of Clinical Oncology 32 (15_suppl), e15187-e15187, 2014 | 2 | 2014 |
| Biweekly gemcitabine and capecitabine in heavily pretreated patients with metastatic colorectal cancer (mCRC). MDP Solis Hernandez, P Jiménez, L Faez Garcia, C Alvarez Fernandez, ... Journal of Clinical Oncology 31 (15_suppl), e14617-e14617, 2013 | 2 | 2013 |
| Atezolizumab Combined With Platinum and Maintenance Niraparib for Recurrent Ovarian Cancer With a Platinum-Free Interval> 6 Months: ENGOT-OV41/GEICO 69-O/ANITA Phase III Trial A González-Martín, MJ Rubio, F Heitz, R Depont Christensen, N Colombo, ... Journal of Clinical Oncology, JCO. 24.00668, 2024 | | 2024 |
| Management challenges in low-grade serous ovarian cancer with a BRCA mutation L Sanchez-Lorenzo, L Sancho, T Iscar, R Grisham, L Chiva International Journal of Gynecological Cancer 34 (4), 631-636, 2024 | | 2024 |
| 930 Exploring the influence of volume center on surgical outcomes in the management of early-stage endometrial cancer: a subanalysis of the SENECA study F Boria, E Chacon, JÁ Mínguez, L Sánchez-Lorenzo, A Gonzalez, L Chiva International Journal of Gynecologic Cancer 34 (Suppl 1), 2024 | | 2024 |
